These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Object recognition impairment and rescue by a dopamine D2 antagonist in hyperdopaminergic mice. França AS; Muratori L; Nascimento GC; Pereira CM; Ribeiro S; Lobão-Soares B Behav Brain Res; 2016 Jul; 308():211-6. PubMed ID: 27059337 [TBL] [Abstract][Full Text] [Related]
4. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake. Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804 [TBL] [Abstract][Full Text] [Related]
5. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor. Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914 [TBL] [Abstract][Full Text] [Related]
6. A behavioral defect of temporal association memory in mice that partly lack dopamine reuptake transporter. Deng S; Zhang L; Zhu T; Liu YM; Zhang H; Shen Y; Li WG; Li F Sci Rep; 2015 Dec; 5():17461. PubMed ID: 26658842 [TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter is downregulated and its association with chaperone protein Hsc70 is enhanced by activation of dopamine D Chang PK; Chien KY; Chen JC Brain Res Bull; 2020 Dec; 165():263-271. PubMed ID: 33049353 [TBL] [Abstract][Full Text] [Related]
8. Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice. Lv Y; Hu RR; Jing M; Zhao TY; Wu N; Song R; Li J; Hu G Acta Pharmacol Sin; 2019 May; 40(5):583-588. PubMed ID: 30224637 [TBL] [Abstract][Full Text] [Related]
12. Episodic-like and procedural memory impairments in histamine H1 Receptor knockout mice coincide with changes in acetylcholine esterase activity in the hippocampus and dopamine turnover in the cerebellum. Dere E; Zlomuzica A; Viggiano D; Ruocco LA; Watanabe T; Sadile AG; Huston JP; De Souza-Silva MA Neuroscience; 2008 Dec; 157(3):532-41. PubMed ID: 18926883 [TBL] [Abstract][Full Text] [Related]
13. Dopamine D(3) receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice. Song R; Zhang HY; Peng XQ; Su RB; Yang RF; Li J; Xi ZX; Gardner EL Neuropharmacology; 2013 Sep; 72():82-7. PubMed ID: 23643749 [TBL] [Abstract][Full Text] [Related]
14. Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Morice E; Billard JM; Denis C; Mathieu F; Betancur C; Epelbaum J; Giros B; Nosten-Bertrand M Neuropsychopharmacology; 2007 Oct; 32(10):2108-16. PubMed ID: 17342172 [TBL] [Abstract][Full Text] [Related]
15. Role of dopamine D3 receptor in alleviating behavioural deficits in animal models of post-traumatic stress disorder. Song D; Ge Y; Chen Z; Shang C; Guo Y; Zhao T; Li Y; Wu N; Song R; Li J Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):190-200. PubMed ID: 29510167 [TBL] [Abstract][Full Text] [Related]
16. Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment. Watson DJ; Marsden CA; Millan MJ; Fone KC Int J Neuropsychopharmacol; 2012 May; 15(4):471-84. PubMed ID: 21414250 [TBL] [Abstract][Full Text] [Related]
17. The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice. Seminerio MJ; Hansen R; Kaushal N; Zhang HT; McCurdy CR; Matsumoto RR Int J Neuropsychopharmacol; 2013 Jun; 16(5):1033-44. PubMed ID: 22932447 [TBL] [Abstract][Full Text] [Related]
18. The antipsychotic-like effects in rodents of YQA31 involve dopamine D3 and 5-HT1A receptor. Gou HY; Sun X; Li F; Wang ZY; Wu N; Su RB; Cong B; Li J Pharmacol Rep; 2017 Dec; 69(6):1125-1130. PubMed ID: 29128790 [TBL] [Abstract][Full Text] [Related]
19. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model. Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965 [TBL] [Abstract][Full Text] [Related]
20. Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. Weiss S; Tzavara ET; Davis RJ; Nomikos GG; Michael McIntosh J; Giros B; Martres MP Neuropharmacology; 2007 Jun; 52(7):1496-508. PubMed ID: 17433376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]